http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2019, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Tue, 04 Dec 2018 17:38:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++3++++++++++Outlook+Therapeutics%2C+++++For%3A+Nov+30++Filed+by%3A+Evanson+Jeff/14892153.html Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++3++++++++++Outlook+Therapeutics%2C+++++For%3A+Nov+30++Filed+by%3A+Evanson+Jeff/14892153.html for the full story. http://www.streetinsider.com/SEC+Filings/Form++3++++++++++Outlook+Therapeutics%2C+++++For%3A+Nov+30++Filed+by%3A+Evanson+Jeff/14892153.html Tue, 04 Dec 2018 17:38:00 -0400 ONS http://www.streetinsider.com/SEC+Filings/Form++3++++++++++Outlook+Therapeutics%2C+++++For%3A+Nov+30++Filed+by%3A+Dagnon+Terry/14892148.html Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++3++++++++++Outlook+Therapeutics%2C+++++For%3A+Nov+30++Filed+by%3A+Dagnon+Terry/14892148.html for the full story. http://www.streetinsider.com/SEC+Filings/Form++3++++++++++Outlook+Therapeutics%2C+++++For%3A+Nov+30++Filed+by%3A+Dagnon+Terry/14892148.html Tue, 04 Dec 2018 17:37:00 -0400 ONS http://www.streetinsider.com/Press+Releases/Oncobiologics+Changes+Name+to+Outlook+Therapeutics%3B+Announces+Next+Steps+in+Executing+ONS-5010+Clinical+and+Regulatory+Strategy/14883672.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Oncobiologics+Changes+Name+to+Outlook+Therapeutics%3B+Announces+Next+Steps+in+Executing+ONS-5010+Clinical+and+Regulatory+Strategy/14883672.html for the full story. http://www.streetinsider.com/Press+Releases/Oncobiologics+Changes+Name+to+Outlook+Therapeutics%3B+Announces+Next+Steps+in+Executing+ONS-5010+Clinical+and+Regulatory+Strategy/14883672.html Mon, 03 Dec 2018 09:15:00 -0400 A.19809304 A.24478717 A.25724027 A.28110669 ONS ONSIW ONSIZ http://www.streetinsider.com/Press+Releases/Oncobiologics+Changes+Name+to+Outlook+Therapeutics%3B+Announces+Next+Steps+in+Executing+ONS-5010+Clinical+and+Regulatory+Strategy/14883672.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Oncobiologics+Changes+Name+to+Outlook+Therapeutics%3B+Announces+Next+Steps+in+Executing+ONS-5010+Clinical+and+Regulatory+Strategy/14883672.html for the full story. http://www.streetinsider.com/Press+Releases/Oncobiologics+Changes+Name+to+Outlook+Therapeutics%3B+Announces+Next+Steps+in+Executing+ONS-5010+Clinical+and+Regulatory+Strategy/14883672.html Mon, 03 Dec 2018 09:15:00 -0400 A.19809304 A.24478717 A.25724027 A.28110669 ONS ONSIW ONSIZ http://www.streetinsider.com/Press+Releases/Oncobiologics+Changes+Name+to+Outlook+Therapeutics%3B+Announces+Next+Steps+in+Executing+ONS-5010+Clinical+and+Regulatory+Strategy/14883672.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Oncobiologics+Changes+Name+to+Outlook+Therapeutics%3B+Announces+Next+Steps+in+Executing+ONS-5010+Clinical+and+Regulatory+Strategy/14883672.html for the full story. http://www.streetinsider.com/Press+Releases/Oncobiologics+Changes+Name+to+Outlook+Therapeutics%3B+Announces+Next+Steps+in+Executing+ONS-5010+Clinical+and+Regulatory+Strategy/14883672.html Mon, 03 Dec 2018 09:15:00 -0400 A.19809304 A.24478717 A.25724027 A.28110669 ONS ONSIW ONSIZ http://www.streetinsider.com/Press+Releases/Oncobiologics+Changes+Name+to+Outlook+Therapeutics%3B+Announces+Next+Steps+in+Executing+ONS-5010+Clinical+and+Regulatory+Strategy/14883672.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Oncobiologics+Changes+Name+to+Outlook+Therapeutics%3B+Announces+Next+Steps+in+Executing+ONS-5010+Clinical+and+Regulatory+Strategy/14883672.html for the full story. http://www.streetinsider.com/Press+Releases/Oncobiologics+Changes+Name+to+Outlook+Therapeutics%3B+Announces+Next+Steps+in+Executing+ONS-5010+Clinical+and+Regulatory+Strategy/14883672.html Mon, 03 Dec 2018 09:15:00 -0400 A.19809304 A.24478717 A.25724027 A.28110669 ONS ONSIW ONSIZ http://www.streetinsider.com/Press+Releases/Oncobiologics+Changes+Name+to+Outlook+Therapeutics%3B+Announces+Next+Steps+in+Executing+ONS-5010+Clinical+and+Regulatory+Strategy/14883672.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Oncobiologics+Changes+Name+to+Outlook+Therapeutics%3B+Announces+Next+Steps+in+Executing+ONS-5010+Clinical+and+Regulatory+Strategy/14883672.html for the full story. http://www.streetinsider.com/Press+Releases/Oncobiologics+Changes+Name+to+Outlook+Therapeutics%3B+Announces+Next+Steps+in+Executing+ONS-5010+Clinical+and+Regulatory+Strategy/14883672.html Mon, 03 Dec 2018 09:15:00 -0400 A.19809304 A.24478717 A.25724027 A.28110669 ONS ONSIW ONSIZ http://www.streetinsider.com/Press+Releases/Oncobiologics+Changes+Name+to+Outlook+Therapeutics%3B+Announces+Next+Steps+in+Executing+ONS-5010+Clinical+and+Regulatory+Strategy/14883672.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Oncobiologics+Changes+Name+to+Outlook+Therapeutics%3B+Announces+Next+Steps+in+Executing+ONS-5010+Clinical+and+Regulatory+Strategy/14883672.html for the full story. http://www.streetinsider.com/Press+Releases/Oncobiologics+Changes+Name+to+Outlook+Therapeutics%3B+Announces+Next+Steps+in+Executing+ONS-5010+Clinical+and+Regulatory+Strategy/14883672.html Mon, 03 Dec 2018 09:15:00 -0400 A.19809304 A.24478717 A.25724027 A.28110669 ONS ONSIW ONSIZ http://www.streetinsider.com/Press+Releases/Oncobiologics+Changes+Name+to+Outlook+Therapeutics%3B+Announces+Next+Steps+in+Executing+ONS-5010+Clinical+and+Regulatory+Strategy/14883672.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Oncobiologics+Changes+Name+to+Outlook+Therapeutics%3B+Announces+Next+Steps+in+Executing+ONS-5010+Clinical+and+Regulatory+Strategy/14883672.html for the full story. http://www.streetinsider.com/Press+Releases/Oncobiologics+Changes+Name+to+Outlook+Therapeutics%3B+Announces+Next+Steps+in+Executing+ONS-5010+Clinical+and+Regulatory+Strategy/14883672.html Mon, 03 Dec 2018 09:15:00 -0400 A.19809304 A.24478717 A.25724027 A.28110669 ONS ONSIW ONSIZ http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Oncobiologics%2C+Inc.+++++++For%3A+Nov+09++Filed+by%3A+Mohan+Pankaj/14823581.html Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Oncobiologics%2C+Inc.+++++++For%3A+Nov+09++Filed+by%3A+Mohan+Pankaj/14823581.html for the full story. http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Oncobiologics%2C+Inc.+++++++For%3A+Nov+09++Filed+by%3A+Mohan+Pankaj/14823581.html Tue, 13 Nov 2018 17:01:00 -0400 ONS http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Oncobiologics%2C+Inc.+++++++For%3A+Nov+09++Filed+by%3A+Windisch+Joerg/14823564.html Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Oncobiologics%2C+Inc.+++++++For%3A+Nov+09++Filed+by%3A+Windisch+Joerg/14823564.html for the full story. http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Oncobiologics%2C+Inc.+++++++For%3A+Nov+09++Filed+by%3A+Windisch+Joerg/14823564.html Tue, 13 Nov 2018 17:00:00 -0400 ONS http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Oncobiologics%2C+Inc.+++++++For%3A+Nov+09++Filed+by%3A+HILZINGER+KURT+J/14823534.html Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Oncobiologics%2C+Inc.+++++++For%3A+Nov+09++Filed+by%3A+HILZINGER+KURT+J/14823534.html for the full story. http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Oncobiologics%2C+Inc.+++++++For%3A+Nov+09++Filed+by%3A+HILZINGER+KURT+J/14823534.html Tue, 13 Nov 2018 16:59:00 -0400 ONS http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Oncobiologics%2C+Inc.+++++++For%3A+Nov+09++Filed+by%3A+THURMAN+RANDY+H/14823512.html Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Oncobiologics%2C+Inc.+++++++For%3A+Nov+09++Filed+by%3A+THURMAN+RANDY+H/14823512.html for the full story. http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Oncobiologics%2C+Inc.+++++++For%3A+Nov+09++Filed+by%3A+THURMAN+RANDY+H/14823512.html Tue, 13 Nov 2018 16:58:00 -0400 ONS http://www.streetinsider.com/Private+Equity/Oncobiologics+%28ONS%29+Commences+1st+Patient+Dosing+in+First+Clinical+Trial+for+ONS-5010%3B+Announces+%2420M+Equity+Financing+Commitment+%26+Debt+Restructuring/14789954.html Visit StreetInsider.com at http://www.streetinsider.com/Private+Equity/Oncobiologics+%28ONS%29+Commences+1st+Patient+Dosing+in+First+Clinical+Trial+for+ONS-5010%3B+Announces+%2420M+Equity+Financing+Commitment+%26+Debt+Restructuring/14789954.html for the full story. http://www.streetinsider.com/Private+Equity/Oncobiologics+%28ONS%29+Commences+1st+Patient+Dosing+in+First+Clinical+Trial+for+ONS-5010%3B+Announces+%2420M+Equity+Financing+Commitment+%26+Debt+Restructuring/14789954.html Tue, 06 Nov 2018 09:06:01 -0400 ONS ONSIW http://www.streetinsider.com/Private+Equity/Oncobiologics+%28ONS%29+Commences+1st+Patient+Dosing+in+First+Clinical+Trial+for+ONS-5010%3B+Announces+%2420M+Equity+Financing+Commitment+%26+Debt+Restructuring/14789954.html Visit StreetInsider.com at http://www.streetinsider.com/Private+Equity/Oncobiologics+%28ONS%29+Commences+1st+Patient+Dosing+in+First+Clinical+Trial+for+ONS-5010%3B+Announces+%2420M+Equity+Financing+Commitment+%26+Debt+Restructuring/14789954.html for the full story. http://www.streetinsider.com/Private+Equity/Oncobiologics+%28ONS%29+Commences+1st+Patient+Dosing+in+First+Clinical+Trial+for+ONS-5010%3B+Announces+%2420M+Equity+Financing+Commitment+%26+Debt+Restructuring/14789954.html Tue, 06 Nov 2018 09:06:01 -0400 ONS ONSIW http://www.streetinsider.com/Corporate+News/Oncobiologics+%28ONS%29+Commences+1st+Patient+Dosing+in+First+Clinical+Trial+for+ONS-5010%3B+Announces+%2420M+Equity+Financing+Commitment+%26+Debt+Restructuring/14789954.html Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Oncobiologics+%28ONS%29+Commences+1st+Patient+Dosing+in+First+Clinical+Trial+for+ONS-5010%3B+Announces+%2420M+Equity+Financing+Commitment+%26+Debt+Restructuring/14789954.html for the full story. http://www.streetinsider.com/Corporate+News/Oncobiologics+%28ONS%29+Commences+1st+Patient+Dosing+in+First+Clinical+Trial+for+ONS-5010%3B+Announces+%2420M+Equity+Financing+Commitment+%26+Debt+Restructuring/14789954.html Tue, 06 Nov 2018 09:06:01 -0400 ONS ONSIW http://www.streetinsider.com/Corporate+News/Oncobiologics+%28ONS%29+Commences+1st+Patient+Dosing+in+First+Clinical+Trial+for+ONS-5010%3B+Announces+%2420M+Equity+Financing+Commitment+%26+Debt+Restructuring/14789954.html Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Oncobiologics+%28ONS%29+Commences+1st+Patient+Dosing+in+First+Clinical+Trial+for+ONS-5010%3B+Announces+%2420M+Equity+Financing+Commitment+%26+Debt+Restructuring/14789954.html for the full story. http://www.streetinsider.com/Corporate+News/Oncobiologics+%28ONS%29+Commences+1st+Patient+Dosing+in+First+Clinical+Trial+for+ONS-5010%3B+Announces+%2420M+Equity+Financing+Commitment+%26+Debt+Restructuring/14789954.html Tue, 06 Nov 2018 09:06:01 -0400 ONS ONSIW http://www.streetinsider.com/FDA/Oncobiologics+%28ONS%29+Commences+1st+Patient+Dosing+in+First+Clinical+Trial+for+ONS-5010%3B+Announces+%2420M+Equity+Financing+Commitment+%26+Debt+Restructuring/14789954.html Visit StreetInsider.com at http://www.streetinsider.com/FDA/Oncobiologics+%28ONS%29+Commences+1st+Patient+Dosing+in+First+Clinical+Trial+for+ONS-5010%3B+Announces+%2420M+Equity+Financing+Commitment+%26+Debt+Restructuring/14789954.html for the full story. http://www.streetinsider.com/FDA/Oncobiologics+%28ONS%29+Commences+1st+Patient+Dosing+in+First+Clinical+Trial+for+ONS-5010%3B+Announces+%2420M+Equity+Financing+Commitment+%26+Debt+Restructuring/14789954.html Tue, 06 Nov 2018 09:06:01 -0400 ONS ONSIW http://www.streetinsider.com/FDA/Oncobiologics+%28ONS%29+Commences+1st+Patient+Dosing+in+First+Clinical+Trial+for+ONS-5010%3B+Announces+%2420M+Equity+Financing+Commitment+%26+Debt+Restructuring/14789954.html Visit StreetInsider.com at http://www.streetinsider.com/FDA/Oncobiologics+%28ONS%29+Commences+1st+Patient+Dosing+in+First+Clinical+Trial+for+ONS-5010%3B+Announces+%2420M+Equity+Financing+Commitment+%26+Debt+Restructuring/14789954.html for the full story. http://www.streetinsider.com/FDA/Oncobiologics+%28ONS%29+Commences+1st+Patient+Dosing+in+First+Clinical+Trial+for+ONS-5010%3B+Announces+%2420M+Equity+Financing+Commitment+%26+Debt+Restructuring/14789954.html Tue, 06 Nov 2018 09:06:01 -0400 ONS ONSIW http://www.streetinsider.com/Management+Comments/Oncobiologics+%28ONS%29+Commences+1st+Patient+Dosing+in+First+Clinical+Trial+for+ONS-5010%3B+Announces+%2420M+Equity+Financing+Commitment+%26+Debt+Restructuring/14789954.html Visit StreetInsider.com at http://www.streetinsider.com/Management+Comments/Oncobiologics+%28ONS%29+Commences+1st+Patient+Dosing+in+First+Clinical+Trial+for+ONS-5010%3B+Announces+%2420M+Equity+Financing+Commitment+%26+Debt+Restructuring/14789954.html for the full story. http://www.streetinsider.com/Management+Comments/Oncobiologics+%28ONS%29+Commences+1st+Patient+Dosing+in+First+Clinical+Trial+for+ONS-5010%3B+Announces+%2420M+Equity+Financing+Commitment+%26+Debt+Restructuring/14789954.html Tue, 06 Nov 2018 09:06:01 -0400 ONS ONSIW http://www.streetinsider.com/Management+Comments/Oncobiologics+%28ONS%29+Commences+1st+Patient+Dosing+in+First+Clinical+Trial+for+ONS-5010%3B+Announces+%2420M+Equity+Financing+Commitment+%26+Debt+Restructuring/14789954.html Visit StreetInsider.com at http://www.streetinsider.com/Management+Comments/Oncobiologics+%28ONS%29+Commences+1st+Patient+Dosing+in+First+Clinical+Trial+for+ONS-5010%3B+Announces+%2420M+Equity+Financing+Commitment+%26+Debt+Restructuring/14789954.html for the full story. http://www.streetinsider.com/Management+Comments/Oncobiologics+%28ONS%29+Commences+1st+Patient+Dosing+in+First+Clinical+Trial+for+ONS-5010%3B+Announces+%2420M+Equity+Financing+Commitment+%26+Debt+Restructuring/14789954.html Tue, 06 Nov 2018 09:06:01 -0400 ONS ONSIW http://www.streetinsider.com/Press+Releases/Oncobiologics+Advances+ONS-5010+into+wet+AMD+Clinical+Trial/14789888.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Oncobiologics+Advances+ONS-5010+into+wet+AMD+Clinical+Trial/14789888.html for the full story. http://www.streetinsider.com/Press+Releases/Oncobiologics+Advances+ONS-5010+into+wet+AMD+Clinical+Trial/14789888.html Tue, 06 Nov 2018 09:00:00 -0400 ONS ONSIW ONSIZ http://www.streetinsider.com/Press+Releases/Oncobiologics+Advances+ONS-5010+into+wet+AMD+Clinical+Trial/14789888.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Oncobiologics+Advances+ONS-5010+into+wet+AMD+Clinical+Trial/14789888.html for the full story. http://www.streetinsider.com/Press+Releases/Oncobiologics+Advances+ONS-5010+into+wet+AMD+Clinical+Trial/14789888.html Tue, 06 Nov 2018 09:00:00 -0400 ONS ONSIW ONSIZ http://www.streetinsider.com/Press+Releases/Oncobiologics+Advances+ONS-5010+into+wet+AMD+Clinical+Trial/14789888.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Oncobiologics+Advances+ONS-5010+into+wet+AMD+Clinical+Trial/14789888.html for the full story. http://www.streetinsider.com/Press+Releases/Oncobiologics+Advances+ONS-5010+into+wet+AMD+Clinical+Trial/14789888.html Tue, 06 Nov 2018 09:00:00 -0400 ONS ONSIW ONSIZ http://www.streetinsider.com/Press+Releases/Oncobiologics+Provides+Business+Update+and+Reports+Third+Quarter+Financial+Results+for+Fiscal+2018/14513774.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Oncobiologics+Provides+Business+Update+and+Reports+Third+Quarter+Financial+Results+for+Fiscal+2018/14513774.html for the full story. http://www.streetinsider.com/Press+Releases/Oncobiologics+Provides+Business+Update+and+Reports+Third+Quarter+Financial+Results+for+Fiscal+2018/14513774.html Tue, 14 Aug 2018 16:15:00 -0400 ONS ONSIW ONSIZ